1,862 results on '"Windecker, S."'
Search Results
2. Effect of alirocumab on quantitative flow ratio and diameter stenosis in non-infarct related arteries from patients with acute myocardial infarction: a PACMAN-AMI randomized clinical trial substudy
3. Interleukin-6 plasma levels are elevated in patients with acute myocardial infarction and predict death or recurrent infarction within 1 year - a case-control study
4. A systematic review of the evidence supporting the use of surgical aortic and mitral valves: an update from the CORE MD consortium
5. Frequency, predictors and clinical outcomes of AMI patients with triple regression of coronary atherosclerosis: A sub-analysis of the PACMAN AMI trial
6. Prognostic impact of atrial fibrillation in patients with paradoxical low-flow low-gradient aortic stenosis undergoing TAVI
7. In patients with acute myocardial infarction interleukin-8 levels are related to impaired renal function and predict recurrent infarction or death at 1-year follow-up - a case-control study
8. Association between quantitative flow ratio and non-target-vessel-related events before planned staged percutaneous coronary intervention in patients with acute coronary syndrome
9. Effect of evolocumab on platelet function in patients with acute coronary syndromes. An analysis of the randomized, double-blind, placebo-controlled EVOPACS Trial
10. Impact of cardiac staging classification in transcatheter aortic valve implantation for major subtypes of severe aortic stenosis
11. 27 A Systematic review of the evidence supporting the use of surgical aortic and mitral valves: an update from the core MD consortium
12. OC 53.5 Clinical Outcomes in Patients with Acute Pulmonary Embolism Undergoing Ultrasound-Assisted Catheter-Directed Thrombolysis
13. Three-Year Outcomes From the Amplatzer Amulet Left Atrial Appendage Occluder Randomised Controlled Trial (Amulet IDE)
14. Twenty-year trends in the prevalence of modifiable cardiovascular risk factors in young acute coronary syndrome patients hospitalized in Switzerland.
15. Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry
16. Peer Review #2 of "Prediction of Ross River virus incidence in Queensland, Australia: building and comparing models (v0.2)"
17. Statin therapy intensity and physical activity after acute coronary syndrome
18. Optimal CW-Doppler derived parameter for the diagnosis of iatrogenic mitral stenosis during transcatheter edge-to-edge repair for mitral regurgitation
19. Acute impact of transcatheter edge-to-edge repair for mitral regurgitation on left ventricular function
20. Causes of death in patients with atrial fibrillation and a recent acute coronary syndrome or percutaneous coronary intervention: insights from the AUGUSTUS trial
21. Interrelation between baseline plaque characteristics and changes in coronary atherosclerosis with the PCSK9-inhibitor alirocumab: insights from the PACMAN-AMI randomized trial
22. Impact of alirocumab added to high-intensity statin therapy on platelet function in AMI patients: a pre-specified substudy of the randomized, placebo-controlled PACMAN-AMI trial
23. 24 Systematic review of strength of evidence supporting the approval and clinical use of high-risk medical devices in cardiovascular medicine: an update from the CORE-MD consortium
24. Heavy weekly alcohol consumption versus binge drinking after an acute coronary syndrome and risk of major adverse cardiovascular events at one year follow up
25. Outcomes of patients presenting with acute coronary syndromes on workdays vs. rest days (SPUM-ACS substudy)
26. Effect of alirocumab added to high-Intensity statin therapy on endothelial function in patients with acute myocardial infarction: a sub-study of the randomized placebo-controlled PACMAN-AMI trial
27. Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: The Bern–Rotterdam diabetes cohort study
28. Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention : insights from the GLOBAL LEADERS trial
29. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis
30. Functional Status After Transcatheter and Surgical Aortic Valve Replacement: 2-Year Analysis From the SURTAVI Trial
31. Revascularization in complex multivessel coronary artery disease after FREEDOM: Is there an indication for PCI and drug-eluting stents?
32. Entfernung von intravaskulären Fremdkörpern
33. Koronarangiographie
34. Effect of Evolocumab on Changes in Coronary Plaque Phenotype in Statin-Treated Patients Following Myocardial Infarction: The HUYGENS Randomised Clinical Trial
35. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis The Task Force for the management of COVID-19 of the European Society of Cardiology
36. Frequency and prognostic impact of periprocedural myocardial infarction determined by various MI definitions in patients with chronic coronary syndromes undergoing percutaneous coronary intervention
37. Systemic immune-inflammation index predicts major adverse cardiovascular events in patients with ST-elevation myocardial infarction
38. Impact of smoking cessation on depression after acute coronary syndrome
39. Potential candidates for transcatheter tricuspid valve interventions after transcatheter aortic valve implantation: predictors and prognosis
40. Sinus of Valsalva Dimension and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation
41. Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis
42. Comparison of risk prediction models in infarct-related cardiogenic shock
43. Status der koronaren Stententwicklung
44. Transseptal implantation of a balloon-expandable transcatheter heart valve in a native mitral annulus for treatment of radiation-induced valvulopathy: 69
45. Temporal trends in the treatment and outcomes of elderly patients with acute coronary syndrome
46. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
47. Predictors of Outcomes Following Transcatheter Edge-to-Edge Mitral Valve Repair
48. Infective Endocarditis After Transcatheter Aortic Valve Replacement
49. 2019 ESC Guidelines for themanagement of patients with supraventricular tachycardia
50. 2020 EAPCI core curriculum for percutaneous cardiovascular interventions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.